Pharmacology and Therapeutics

  1. Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations

    1. Catia Marzolini
    2. Felix Stader
    3. Marcel Stoeckle
    4. Fabian Franzeck
    5. Adrian Egli
    6. Stefano Bassetti
    7. Alexa Hollinger
    8. Michael Osthoff
    9. Maja Weisser
    10. Caroline E. Gebhard
    11. Veronika Baettig
    12. Julia Geenen
    13. Nina Khanna
    14. Sarah Tschudin-Sutter
    15. Daniel Mueller
    16. Hans H. Hirsch
    17. Manuel Battegay
    18. Parham Sendi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Role of pharmacist during the COVID-19 pandemic: A scoping review

    1. Marília Berlofa Visacri
    2. Isabel Vitória Figueiredo
    3. Tácio de Mendonça Lima

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Global research trend in the treatment of the new Coronavirus diseases (COVID-19): bibliometric analysis

    1. Maxime Descartes Mbogning Fonkou
    2. Abdourahamane Yacouba

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review

    1. Beatriz Oda Plasencia-García
    2. Gonzalo Rodríguez-Menéndez
    3. María Isabel Rico-Rangel
    4. Ana Rubio-García
    5. Jaime Torelló-Iserte
    6. Benedicto Crespo-Facorro

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety

    1. Michael Takla
    2. Kamalan Jeevaratnam

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Investigational Treatments for COVID‐19 may Increase Ventricular Arrhythmia Risk Through Drug Interactions

    1. Meera Varshneya
    2. Itziar Irurzun-Arana
    3. Chiara Campana
    4. Rafael Dariolli
    5. Amy Gutierrez
    6. Taylor K. Pullinger
    7. Eric A. Sobie

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Drug treatments affecting ACE2 in COVID-19 infection: a systematic review protocol

    1. Hajira Dambha-Miller
    2. Ali Albasri
    3. Sam Hodgson
    4. Christopher Wilcox
    5. Nazrul Islam
    6. Shareen Khan
    7. Paul Little
    8. Simon Griffin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports

    1. Isaac V. Cohen
    2. Tigran Makunts
    3. Talar Moumedjian
    4. Masara A. Issa
    5. Ruben Abagyan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients

    1. Laurent Chouchana
    2. Sana Boujaafar
    3. Ines Gana
    4. Laure-Hélène Preta
    5. Lucile Regard
    6. Paul Legendre
    7. Celia Azoulay
    8. Etienne Canouï
    9. Jeremie Zerbit
    10. Nicolas Carlier
    11. Benjamin Terrier
    12. Solen Kernéis
    13. Rui Batista
    14. Jean-Marc Treluyer
    15. Yi Zheng
    16. Sihem Benaboud

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Low blood sodium increases risk and severity of COVID-19: a systematic review, meta-analysis and retrospective cohort study

    1. Yi Luo
    2. Yirong Li
    3. Jiapei Dai

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Page 1 of 8 Next